| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04070040 | Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) | Primary Central Nervous System Lymphoma | Recruiting |
| NCT04267978 | Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in… | Glioblastoma, Recurrent | Recruiting |
| NCT04501718 | Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent… | Recurrent Medulloblastoma | Recruiting |
| NCT05278715 | Modified CV Regimen in Optic Pathway Glioma | Optic Glioma | Recruiting |
| Not specified | |||
| NCT04501705 | Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults | Recurrent Atypical/malignant Meningioma | Recruiting |
| NCT06894238 | Electroencephalogram Predicts Post-operative Delirium | Neurosurgery | Recruiting |
| NCT05836701 | Retrospective Study of Germ Cell Tumors of the Central Nervous System | Germ Cell Tumor of CNS | Active, Not Recruiting |